De Simone, and N. D’Agostino, place blood transcriptomics at the center of an effort to detect Parkinson’s disease during its earliest biological stages. The reported U1-snRNP repression and miRNA–mRNA hubs may offer new hypotheses for understanding how early molecular disturbances develop and how they could eventually be tracked. Subject of Research: Blood transcriptomics and miRNA–mRNA regulatory mechanisms in pre-clinical Parkinson’s diseaseArticle Title: Integrative blood transcriptomics identifies U1-snRNP gene repression and miRNA–mRNA regulatory hubs in pre-clinical Parkinson’s diseaseArticle References: D’Angelo, D., De Simone, A. & D’Agostino, N. “Integrative blood transcriptomics identifies U1-snRNP gene repression and miRNA–mRNA regulatory hubs in pre-clinical Parkinson’s disease.” https://doi.org/10.1038/s41531-026-01526-1Image Credits: AI GeneratedDOI: 10.1038/s41531-026-01526-1Keywords: Parkinson’s disease, pre-clinical Parkinson’s disease, blood transcriptomics, U1-snRNP, RNA splicing, microRNA, mRNA regulation, molecular biomarkers, systems biology